According to Latest Research, the global market for CAR-T Cell Therapy should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China CAR-T Cell Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States CAR-T Cell Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, CD19 segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Non-hodgkin Lymphoma has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of CAR-T Cell Therapy include Bristol Myers Squibb, Gilead Sciences, Novartis, Autolus, Janssen, JW Therapeutics, Beijing Immunochina Medical Science & Technology and Bioray Laboratories, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for CAR-T Cell Therapy. Report Highlights:

(1) Global CAR-T Cell Therapy market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global CAR-T Cell Therapy market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China CAR-T Cell Therapy market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global CAR-T Cell Therapy segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global CAR-T Cell Therapy segment by type and by application and regional segment by type and by application.

(6) Global major production regions of CAR-T Cell Therapy, capacity, production and trends.

(7) CAR-T Cell Therapy industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

CD19

BCMA

CD19/CD22

Other

Market segment by application, can be divided into

Non-hodgkin Lymphoma

Multiple Myeloma

Acute Lymphoblastic Leukemia

Other

Market segment by players, this report covers

Bristol Myers Squibb

Gilead Sciences

Novartis

Autolus

Janssen

JW Therapeutics

Beijing Immunochina Medical Science & Technology

Bioray Laboratories

1 Market Overview

1.1 CAR-T Cell Therapy Definition

1.2 Global CAR-T Cell Therapy Market Size and Forecast

1.2.1 By Revenue, Global CAR-T Cell Therapy Market Size, 2018-2029

1.2.2 By Sales Volume, Global CAR-T Cell Therapy Market Size, 2018-2029

1.2.3 Global CAR-T Cell Therapy Price Trend, 2018-2029

1.3 China CAR-T Cell Therapy Market Size and Forecast

1.3.1 By Revenue, China CAR-T Cell Therapy Market Size, 2018-2029

1.3.2 By Sales Volume, China CAR-T Cell Therapy Market Size, 2018-2029

1.3.3 China CAR-T Cell Therapy Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China CAR-T Cell Therapy Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China CAR-T Cell Therapy Share in Global Market, 2018-2029

1.4.3 CAR-T Cell Therapy Market Size: China VS Global, 2018-2029

1.5 CAR-T Cell Therapy Market Dynamics

1.5.1 CAR-T Cell Therapy Market Drivers

1.5.2 CAR-T Cell Therapy Market Restraints

1.5.3 CAR-T Cell Therapy Industry Trends

1.5.4 CAR-T Cell Therapy Industry Policy

2 Global Competitive Landscape by Company

2.1 Global CAR-T Cell Therapy Revenue by Company, 2018-2023

2.2 Global CAR-T Cell Therapy Sales Volume by Company, 2018-2023

2.3 Global CAR-T Cell Therapy Price by Company, 2018-2023

2.4 Global CAR-T Cell Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global CAR-T Cell Therapy Concentration Ratio

2.6 Global CAR-T Cell Therapy Mergers & Acquisitions, Expansion Plans

2.7 Global CAR-T Cell Therapy Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China CAR-T Cell Therapy Revenue by Company, 2018-2023

3.2 China CAR-T Cell Therapy Sales Volume by Company, 2018-2023

3.3 China CAR-T Cell Therapy CAR-T Cell Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China CAR-T Cell Therapy Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, CAR-T Cell Therapy Domestic VS Export

3.6 China Market, CAR-T Cell Therapy Import & Export

3.6.1 China Market, CAR-T Cell Therapy Import & Export, 2018-2029

3.6.2 China CAR-T Cell Therapy Import & Export Trends

3.6.3 Main Sources of China CAR-T Cell Therapy Import

3.6.4 Export Destination of China CAR-T Cell Therapy

4 CAR-T Cell Therapy Production by Region

4.1 Global CAR-T Cell Therapy Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of CAR-T Cell Therapy Manufacturers

4.3 Global Major Manufacturers, CAR-T Cell Therapy Capacity Expansion and Future Plans

4.4 Global CAR-T Cell Therapy Capacity by Region

4.5 Global CAR-T Cell Therapy Production by Region

4.5.1 Global CAR-T Cell Therapy Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global CAR-T Cell Therapy Production by Region, 2018-2023

4.5.3 Global CAR-T Cell Therapy Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 CAR-T Cell Therapy Industry Chain

5.2 CAR-T Cell Therapy Upstream Analysis

5.2.1 CAR-T Cell Therapy Core Raw Materials

5.2.2 Main Manufacturers of CAR-T Cell Therapy Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 CAR-T Cell Therapy Production Mode

5.6 CAR-T Cell Therapy Procurement Model

5.7 CAR-T Cell Therapy Industry Sales Model and Sales Channels

5.7.1 CAR-T Cell Therapy Sales Model

5.7.2 CAR-T Cell Therapy Typical Distributors

6 Sights by Type

6.1 CAR-T Cell Therapy Classification

6.1.1 CD19

6.1.2 BCMA

6.1.3 CD19/CD22

6.1.4 Other

6.2 By Type, Global CAR-T Cell Therapy Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global CAR-T Cell Therapy Revenue, 2018-2029

6.4 By Type, Global CAR-T Cell Therapy Sales Volume, 2018-2029

6.5 By Type, Global CAR-T Cell Therapy Price, 2018-2029

7 Sights by Application

7.1 CAR-T Cell Therapy Segment by Application

7.1.1 Non-hodgkin Lymphoma

7.1.2 Multiple Myeloma

7.1.3 Acute Lymphoblastic Leukemia

7.1.4 Other

7.2 By Application, Global CAR-T Cell Therapy Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global CAR-T Cell Therapy Revenue, 2018-2029

7.4 By Application, Global CAR-T Cell Therapy Sales Volume, 2018-2029

7.5 By Application, Global CAR-T Cell Therapy Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global CAR-T Cell Therapy Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global CAR-T Cell Therapy Revenue, 2018-2029

8.3 By Region, Global CAR-T Cell Therapy Sales Volume, 2018-2029

8.4 North America

8.4.1 North America CAR-T Cell Therapy Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America CAR-T Cell Therapy Market Size Market Share

8.5 Europe

8.5.1 Europe CAR-T Cell Therapy Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe CAR-T Cell Therapy Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific CAR-T Cell Therapy Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific CAR-T Cell Therapy Market Size Market Share

8.7 South America

8.7.1 South America CAR-T Cell Therapy Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America CAR-T Cell Therapy Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global CAR-T Cell Therapy Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global CAR-T Cell Therapy Revenue, 2018-2029

9.3 By Country, Global CAR-T Cell Therapy Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. CAR-T Cell Therapy Market Size, 2018-2029

9.4.2 By Company, U.S. CAR-T Cell Therapy Sales Volume Market Share, 2022

9.4.3 By Type, U.S. CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe CAR-T Cell Therapy Market Size, 2018-2029

9.5.2 By Company, Europe CAR-T Cell Therapy Sales Volume Market Share, 2022

9.5.3 By Type, Europe CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China CAR-T Cell Therapy Market Size, 2018-2029

9.6.2 By Company, China CAR-T Cell Therapy Sales Volume Market Share, 2022

9.6.3 By Type, China CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.6.4 By Application, China CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan CAR-T Cell Therapy Market Size, 2018-2029

9.7.2 By Company, Japan CAR-T Cell Therapy Sales Volume Market Share, 2022

9.7.3 By Type, Japan CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea CAR-T Cell Therapy Market Size, 2018-2029

9.8.2 By Company, South Korea CAR-T Cell Therapy Sales Volume Market Share, 2022

9.8.3 By Type, South Korea CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia CAR-T Cell Therapy Market Size, 2018-2029

9.9.2 By Company, Southeast Asia CAR-T Cell Therapy Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India CAR-T Cell Therapy Market Size, 2018-2029

9.10.2 By Company, India CAR-T Cell Therapy Sales Volume Market Share, 2022

9.10.3 By Type, India CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.10.4 By Application, India CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia CAR-T Cell Therapy Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia CAR-T Cell Therapy Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia CAR-T Cell Therapy Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Bristol Myers Squibb

10.1.1 Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position

10.1.2 Bristol Myers Squibb CAR-T Cell Therapy Models, Specifications and Application

10.1.3 Bristol Myers Squibb CAR-T Cell Therapy Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Bristol Myers Squibb Company Profile and Main Business

10.1.5 Bristol Myers Squibb Recent Developments

10.2 Gilead Sciences

10.2.1 Gilead Sciences Company Information, Head Office, Market Area and Industry Position

10.2.2 Gilead Sciences CAR-T Cell Therapy Models, Specifications and Application

10.2.3 Gilead Sciences CAR-T Cell Therapy Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Gilead Sciences Company Profile and Main Business

10.2.5 Gilead Sciences Recent Developments

10.3 Novartis

10.3.1 Novartis Company Information, Head Office, Market Area and Industry Position

10.3.2 Novartis CAR-T Cell Therapy Models, Specifications and Application

10.3.3 Novartis CAR-T Cell Therapy Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Novartis Company Profile and Main Business

10.3.5 Novartis Recent Developments

10.4 Autolus

10.4.1 Autolus Company Information, Head Office, Market Area and Industry Position

10.4.2 Autolus CAR-T Cell Therapy Models, Specifications and Application

10.4.3 Autolus CAR-T Cell Therapy Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Autolus Company Profile and Main Business

10.4.5 Autolus Recent Developments

10.5 Janssen

10.5.1 Janssen Company Information, Head Office, Market Area and Industry Position

10.5.2 Janssen CAR-T Cell Therapy Models, Specifications and Application

10.5.3 Janssen CAR-T Cell Therapy Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Janssen Company Profile and Main Business

10.5.5 Janssen Recent Developments

10.6 JW Therapeutics

10.6.1 JW Therapeutics Company Information, Head Office, Market Area and Industry Position

10.6.2 JW Therapeutics CAR-T Cell Therapy Models, Specifications and Application

10.6.3 JW Therapeutics CAR-T Cell Therapy Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 JW Therapeutics Company Profile and Main Business

10.6.5 JW Therapeutics Recent Developments

10.7 Beijing Immunochina Medical Science & Technology

10.7.1 Beijing Immunochina Medical Science & Technology Company Information, Head Office, Market Area and Industry Position

10.7.2 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Models, Specifications and Application

10.7.3 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Beijing Immunochina Medical Science & Technology Company Profile and Main Business

10.7.5 Beijing Immunochina Medical Science & Technology Recent Developments

10.8 Bioray Laboratories

10.8.1 Bioray Laboratories Company Information, Head Office, Market Area and Industry Position

10.8.2 Bioray Laboratories CAR-T Cell Therapy Models, Specifications and Application

10.8.3 Bioray Laboratories CAR-T Cell Therapy Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Bioray Laboratories Company Profile and Main Business

10.8.5 Bioray Laboratories Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. CAR-T Cell Therapy Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. CAR-T Cell Therapy Market Restraints

Table 3. CAR-T Cell Therapy Market Trends

Table 4. CAR-T Cell Therapy Industry Policy

Table 5. Global CAR-T Cell Therapy Revenue by Company, 2018-2023, US$ million

Table 6. Global CAR-T Cell Therapy Revenue Market Share by Company, 2018-2023

Table 7. Global CAR-T Cell Therapy Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global CAR-T Cell Therapy Sales Volume Market Share by Company, 2018-2023

Table 9. Global CAR-T Cell Therapy Price by Company, 2018-2023, (US$/Unit)

Table 10. Global CAR-T Cell Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global CAR-T Cell Therapy Mergers & Acquisitions, Expansion Plans

Table 12. Global CAR-T Cell Therapy Manufacturers Product Type

Table 13. China CAR-T Cell Therapy Revenue by Company, 2018-2023, US$ million

Table 14. China CAR-T Cell Therapy Revenue Market Share by Company, 2018-2023

Table 15. China CAR-T Cell Therapy Sales Volume by Company, 2018-2023, (K Units)

Table 16. China CAR-T Cell Therapy Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, CAR-T Cell Therapy Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China CAR-T Cell Therapy Import & Export Trends

Table 19. Main Sources of China CAR-T Cell Therapy Import

Table 20. Export Destination of China CAR-T Cell Therapy

Table 21. Global Headquarters and Manufacturing Base of CAR-T Cell Therapy Manufacturers

Table 22. Global Major Manufacturers, CAR-T Cell Therapy Capacity Expansion and Future Plans

Table 23. Global CAR-T Cell Therapy Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global CAR-T Cell Therapy Production by Region, 2018-2023, (K Units)

Table 25. Global CAR-T Cell Therapy Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of CAR-T Cell Therapy Upstream (Raw Materials)

Table 27. Global CAR-T Cell Therapy Typical Customers

Table 28. CAR-T Cell Therapy Typical Distributors

Table 29. By Type, Global CAR-T Cell Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global CAR-T Cell Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global CAR-T Cell Therapy Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global CAR-T Cell Therapy Revenue, 2018-2029, US$ Million

Table 33. By Region, Global CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global CAR-T Cell Therapy Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global CAR-T Cell Therapy Revenue, 2018-2029, US$ Million

Table 36. By Country, Global CAR-T Cell Therapy Revenue Market Share, 2018-2029

Table 37. By Country, Global CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global CAR-T Cell Therapy Sales Volume Market Share, 2018-2029

Table 39. Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position

Table 40. Bristol Myers Squibb CAR-T Cell Therapy Models, Specifications and Application

Table 41. Bristol Myers Squibb CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Bristol Myers Squibb Company Profile and Main Business

Table 43. Bristol Myers Squibb Recent Developments

Table 44. Gilead Sciences Company Information, Head Office, Market Area and Industry Position

Table 45. Gilead Sciences CAR-T Cell Therapy Models, Specifications and Application

Table 46. Gilead Sciences CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Gilead Sciences Company Profile and Main Business

Table 48. Gilead Sciences Recent Developments

Table 49. Novartis Company Information, Head Office, Market Area and Industry Position

Table 50. Novartis CAR-T Cell Therapy Models, Specifications and Application

Table 51. Novartis CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Novartis Company Profile and Main Business

Table 53. Novartis Recent Developments

Table 54. Autolus Company Information, Head Office, Market Area and Industry Position

Table 55. Autolus CAR-T Cell Therapy Models, Specifications and Application

Table 56. Autolus CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Autolus Company Profile and Main Business

Table 58. Autolus Recent Developments

Table 59. Janssen Company Information, Head Office, Market Area and Industry Position

Table 60. Janssen CAR-T Cell Therapy Models, Specifications and Application

Table 61. Janssen CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Janssen Company Profile and Main Business

Table 63. Janssen Recent Developments

Table 64. JW Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 65. JW Therapeutics CAR-T Cell Therapy Models, Specifications and Application

Table 66. JW Therapeutics CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. JW Therapeutics Company Profile and Main Business

Table 68. JW Therapeutics Recent Developments

Table 69. Beijing Immunochina Medical Science & Technology Company Information, Head Office, Market Area and Industry Position

Table 70. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Models, Specifications and Application

Table 71. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Beijing Immunochina Medical Science & Technology Company Profile and Main Business

Table 73. Beijing Immunochina Medical Science & Technology Recent Developments

Table 74. Bioray Laboratories Company Information, Head Office, Market Area and Industry Position

Table 75. Bioray Laboratories CAR-T Cell Therapy Models, Specifications and Application

Table 76. Bioray Laboratories CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Bioray Laboratories Company Profile and Main Business

Table 78. Bioray Laboratories Recent Developments

List of Figure

Figure 1. CAR-T Cell Therapy Picture

Figure 2. By Revenue, Global CAR-T Cell Therapy Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global CAR-T Cell Therapy Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global CAR-T Cell Therapy Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China CAR-T Cell Therapy Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China CAR-T Cell Therapy Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China CAR-T Cell Therapy Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China CAR-T Cell Therapy Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China CAR-T Cell Therapy Share of Global Market, 2018-2029

Figure 10. Global CAR-T Cell Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global CAR-T Cell Therapy Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China CAR-T Cell Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China CAR-T Cell Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China CAR-T Cell Therapy Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of CAR-T Cell Therapy Domestic VS Export, 2022

Figure 16. Global CAR-T Cell Therapy Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global CAR-T Cell Therapy Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global CAR-T Cell Therapy Production Market Share & Forecast by Region, 2018-2029

Figure 19. CAR-T Cell Therapy Industry Chain

Figure 20. CAR-T Cell Therapy Procurement Model

Figure 21. CAR-T Cell Therapy Sales Model

Figure 22. CAR-T Cell Therapy Sales Channels, Direct Sales and Distribution

Figure 23. CD19

Figure 24. BCMA

Figure 25. CD19/CD22

Figure 26. Other

Figure 27. By Type, Global CAR-T Cell Therapy Revenue, 2018-2029, US$ Million

Figure 28. By Type, Global CAR-T Cell Therapy Revenue Market Share, 2018-2029

Figure 29. By Type, Global CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Figure 30. By Type, Global CAR-T Cell Therapy Sales Volume Market Share, 2018-2029

Figure 31. By Type, Global CAR-T Cell Therapy Price, 2018-2029, (US$/Unit)

Figure 32. Non-hodgkin Lymphoma

Figure 33. Multiple Myeloma

Figure 34. Acute Lymphoblastic Leukemia

Figure 35. Other

Figure 36. By Application, Global CAR-T Cell Therapy Revenue, 2018-2029, US$ Million

Figure 37. By Application, Global CAR-T Cell Therapy Revenue Market Share, 2018-2029

Figure 38. By Application, Global CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Figure 39. By Application, Global CAR-T Cell Therapy Sales Volume Market Share, 2018-2029

Figure 40. By Application, Global CAR-T Cell Therapy Price, 2018-2029, (US$/Unit)

Figure 41. By Region, Global CAR-T Cell Therapy Revenue Market Share, 2018-2029

Figure 42. By Region, Global CAR-T Cell Therapy Sales Volume Market Share, 2018-2029

Figure 43. North America CAR-T Cell Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 44. By Country, North America CAR-T Cell Therapy Revenue Market Share, 2022

Figure 45. Europe CAR-T Cell Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, Europe CAR-T Cell Therapy Revenue Market Share, 2022

Figure 47. Asia Pacific CAR-T Cell Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 48. By Country/Region, Asia Pacific CAR-T Cell Therapy Revenue Market Share, 2022

Figure 49. South America CAR-T Cell Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 50. By Country, South America CAR-T Cell Therapy Revenue Market Share, 2022

Figure 51. Middle East & Africa CAR-T Cell Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 52. U.S. CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Figure 53. By Company, U.S. CAR-T Cell Therapy Market Share, 2022

Figure 54. By Type, U.S. CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 55. By Application, U.S. CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 56. Europe CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Figure 57. By Company, Europe CAR-T Cell Therapy Market Share, 2022

Figure 58. By Type, Europe CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 59. By Application, Europe CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 60. China CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Figure 61. By Company, China CAR-T Cell Therapy Market Share, 2022

Figure 62. By Type, China CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 63. By Application, China CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 64. Japan CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Figure 65. By Company, Japan CAR-T Cell Therapy Market Share, 2022

Figure 66. By Type, Japan CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 67. By Application, Japan CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 68. South Korea CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Figure 69. By Company, South Korea CAR-T Cell Therapy Market Share, 2022

Figure 70. By Type, South Korea CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 71. By Application, South Korea CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 72. Southeast Asia CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Figure 73. By Company, Southeast Asia CAR-T Cell Therapy Market Share, 2022

Figure 74. By Type, Southeast Asia CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 75. By Application, Southeast Asia CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 76. India CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Figure 77. By Company, India CAR-T Cell Therapy Market Share, 2022

Figure 78. By Type, India CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 79. By Application, India CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 80. Middle East & Asia CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Figure 81. By Company, Middle East & Asia CAR-T Cell Therapy Market Share, 2022

Figure 82. By Type, Middle East & Asia CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 83. By Application, Middle East & Asia CAR-T Cell Therapy Sales Volume Market Share, 2022 VS 2029

Figure 84. Research Methodology

Figure 85. Breakdown of Primary Interviews

Figure 86. Bottom-up Approaches

Figure 87. Top-down Approaches

Table 1. CAR-T Cell Therapy Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. CAR-T Cell Therapy Market Restraints

Table 3. CAR-T Cell Therapy Market Trends

Table 4. CAR-T Cell Therapy Industry Policy

Table 5. Global CAR-T Cell Therapy Revenue by Company, 2018-2023, US$ million

Table 6. Global CAR-T Cell Therapy Revenue Market Share by Company, 2018-2023

Table 7. Global CAR-T Cell Therapy Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global CAR-T Cell Therapy Sales Volume Market Share by Company, 2018-2023

Table 9. Global CAR-T Cell Therapy Price by Company, 2018-2023, (US$/Unit)

Table 10. Global CAR-T Cell Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global CAR-T Cell Therapy Mergers & Acquisitions, Expansion Plans

Table 12. Global CAR-T Cell Therapy Manufacturers Product Type

Table 13. China CAR-T Cell Therapy Revenue by Company, 2018-2023, US$ million

Table 14. China CAR-T Cell Therapy Revenue Market Share by Company, 2018-2023

Table 15. China CAR-T Cell Therapy Sales Volume by Company, 2018-2023, (K Units)

Table 16. China CAR-T Cell Therapy Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, CAR-T Cell Therapy Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China CAR-T Cell Therapy Import & Export Trends

Table 19. Main Sources of China CAR-T Cell Therapy Import

Table 20. Export Destination of China CAR-T Cell Therapy

Table 21. Global Headquarters and Manufacturing Base of CAR-T Cell Therapy Manufacturers

Table 22. Global Major Manufacturers, CAR-T Cell Therapy Capacity Expansion and Future Plans

Table 23. Global CAR-T Cell Therapy Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global CAR-T Cell Therapy Production by Region, 2018-2023, (K Units)

Table 25. Global CAR-T Cell Therapy Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of CAR-T Cell Therapy Upstream (Raw Materials)

Table 27. Global CAR-T Cell Therapy Typical Customers

Table 28. CAR-T Cell Therapy Typical Distributors

Table 29. By Type, Global CAR-T Cell Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global CAR-T Cell Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global CAR-T Cell Therapy Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global CAR-T Cell Therapy Revenue, 2018-2029, US$ Million

Table 33. By Region, Global CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global CAR-T Cell Therapy Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global CAR-T Cell Therapy Revenue, 2018-2029, US$ Million

Table 36. By Country, Global CAR-T Cell Therapy Revenue Market Share, 2018-2029

Table 37. By Country, Global CAR-T Cell Therapy Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global CAR-T Cell Therapy Sales Volume Market Share, 2018-2029

Table 39. Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position

Table 40. Bristol Myers Squibb CAR-T Cell Therapy Models, Specifications and Application

Table 41. Bristol Myers Squibb CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Bristol Myers Squibb Company Profile and Main Business

Table 43. Bristol Myers Squibb Recent Developments

Table 44. Gilead Sciences Company Information, Head Office, Market Area and Industry Position

Table 45. Gilead Sciences CAR-T Cell Therapy Models, Specifications and Application

Table 46. Gilead Sciences CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Gilead Sciences Company Profile and Main Business

Table 48. Gilead Sciences Recent Developments

Table 49. Novartis Company Information, Head Office, Market Area and Industry Position

Table 50. Novartis CAR-T Cell Therapy Models, Specifications and Application

Table 51. Novartis CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Novartis Company Profile and Main Business

Table 53. Novartis Recent Developments

Table 54. Autolus Company Information, Head Office, Market Area and Industry Position

Table 55. Autolus CAR-T Cell Therapy Models, Specifications and Application

Table 56. Autolus CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Autolus Company Profile and Main Business

Table 58. Autolus Recent Developments

Table 59. Janssen Company Information, Head Office, Market Area and Industry Position

Table 60. Janssen CAR-T Cell Therapy Models, Specifications and Application

Table 61. Janssen CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Janssen Company Profile and Main Business

Table 63. Janssen Recent Developments

Table 64. JW Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 65. JW Therapeutics CAR-T Cell Therapy Models, Specifications and Application

Table 66. JW Therapeutics CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. JW Therapeutics Company Profile and Main Business

Table 68. JW Therapeutics Recent Developments

Table 69. Beijing Immunochina Medical Science & Technology Company Information, Head Office, Market Area and Industry Position

Table 70. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Models, Specifications and Application

Table 71. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Beijing Immunochina Medical Science & Technology Company Profile and Main Business

Table 73. Beijing Immunochina Medical Science & Technology Recent Developments

Table 74. Bioray Laboratories Company I

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)